PubMed · 2002 · 201 citations · 19 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyTumor PathologyApoptosis In CancerApoptosis PharmacologyBladder CancerPharmacodynamics Of Anticancer AgentsPharmacodynamics Of Anticancer DrugsUrothelial CarcinomaCanine Transitional Cell CarcinomaCyclooxygenase InhibitorsCyclooxygenase Pathway SignalingCyclooxygenase PathwaysCyclooxygenase-2 PathwayProliferative IndexTumor Response EvaluationVascular Endothelial Growth Factor
The mechanisms by which cyclooxygenase inhibitors exert antitumor effects are not completely defined but are postulated to involve antiangiogenic effects and induction of apoptosis. In this study, we determined the effects of the cox inhibitor, piroxicam, on tumor response, apoptotic index, proliferative index, cyclooxygenase-2 expression, prostaglandin E(2) concentration, tumor microvessel density, and urine basic fibroblast growth factor and vascular endothelial growth factor concentrations in pet dogs with naturally occurring invasive transitional cell carcinoma of the urinary bladder. Piroxicam caused reduction in tumor volume in 12 of 18 dogs, and this was strongly associated with induction of apoptosis (Fisher's exact test P < 0.015) and reduction in urine basic fibroblast growth factor concentration.
19
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
Robert A. Soslow, Andrew J. Dannenberg, Demaretta Rush et al. · Cancer · 2000 · 872 citations
Molecular pathology of cyclooxygenase-2 in neoplasia.
E Fosslien · PubMed · 2000 · 400 citations
Medicine, Oncology, Pharmacology +15
Expression of cyclooxygenase-2 in prostate carcinoma
Rikio Yoshimura, Hajime Sano, Chikayosi Masuda et al. · Cancer · 2000 · 323 citations
Medicine, Oncology, Pharmacology +12